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How did a country physician in 19th century Europe emerge as an icon in the world of medicine for all times to 
come? What inspires and motivates a discoverer to 
achieve what many observed and debated before 
him but were unable to achieve? What sweat 
and toil culminate in irrefutable evidence that 
peers accept and generations follow, expand and 
investigate? Is a landmark discovery, invention or 
innovation merely an idea whose time has come? 
The succeeding paragraphs illustrate how one man’s 
life and times provide an answer to these complex 
questions and forever relegate the pre-Koch era of 
tuberculosis (TB) to antiquity.3
Born Heinrich Hermann Robert Koch, in 1843, 
this Prussian physician’s abbreviated name ‘Robert 
Koch’ became a byword in infectious diseases 
practice, for having identified the bacillary aetiology 
of TB, the 19th century scourge.4 The enormous 
public health impact of this discovery on a disease 
that, at the time, claimed the lives of humans 
in epidemic proportions, overshadowed his 
first contribution to the field of bacteriology: 
the identification of the Bacillus anthracis. The 
juggernaut of bacterial discoveries continued 
with the identification of the Staphylococcus 
species (wound infections) and the Vibrio cholerae 
bacterium (cholera).5 
The Pied Piper of 
Bacteriology
The date of Friday 24th March 1882 became a 
milestone in medical microbiology when Koch’s 
brilliant exposition of his findings on TB was 
witnessed, in the reading room of the library of 
the Institute of Physiology at 7pm, by the dazzled 
fraternity of the Berlin Physiological Society.4 He 
explained and illustrated all the scientific evidence, 
which his laboratory and animal experiments 
had yielded for the identification and isolation 
of the tubercle bacillus and demonstrated its 
transmissible nature and how it caused TB in man. 
Four seminal papers followed that stamped his 
mark on his discovery.6 This new concept of an 
exogenous agent initiating disease challenged and 
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Seldom has an investigator been able to comprehend in advance with such 
clear-sightedness a new, unbroken field of investigation, and seldom has 
someone succeeded in working on it with the brilliance and success with which 
Robert Koch has done. Seldom have so many discoveries of such decisive 
significance to humanity stemmed from the activity of a single man, as is the 
case with him.1
Nobel Prize for Medicine or Physiology, Presentation Speech, Professor the 
Count K.A.H. Mörner, Rector of the Royal Caroline Institute (Karolinska 
Institute), Stockholm, Sweden, 10th December 1905.2
Robert Koch (1843–1910)1
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decimated the prevailing concept (spearheaded 
by luminaries like Virchow) that all diseases were 
endogenous in origin.7 Koch’s labour of love, that 
unveiled the anthrax and tubercle bacilli, was 
to spawn a generation of ‘microbe hunters’ who 
rapidly identified and linked specific bacteria to the 
diseases they caused.
In 1884, Koch’s assistant, Loeffler, and his 
pupil, Kaffky, identified the diphtheria and 
typhoid bacillus, respectively.8 In a span of thirty 
years, beginning from 1876, at least 20 bacterial 
pathogens were identified for a host of diseases 
including gonorrhoea, tetanus, pneumonia and the 
plague—all killers of those times.5 Ehrlich modified 
Koch’s staining techniques and Gram, Ziehl and 
Neelsen found their names embedded in laboratory 
manuals through the stains they developed which 
we still use today. It deserves mention that Koch, 
a prolific explorer and intrepid traveller, dabbled in 
the investigation of a variety of tropical illnesses, 
like the plague, dysentery, trachoma, typhus and a 
host of veterinary infections. The Pied Piper’s tune 
(translated here as Koch’s ‘style’ of research) was 
thus not a call to doom but heralded the light of 
knowledge and life for humankind. The blueprint 
for identifying infectious pathogens had been 
developed and treatment was just a few steps away.
To See what Everyone 
has Seen; to Think what 
No One has Thought
The foundation of Koch’s principles lay in the 
scientific legacy Koch inherited from his teachers 
Henle, Meissner, Wohler and Krause at the 
University of Göttingen.9,10 Pasteur’s contribution 
to wound sepsis and Lister’s disinfection techniques 
had already made inroads in the warfare against 
germs. Villemin, Cohnheim and others had 
encouraged acceptance of the communicability of 
infection.11 Early in his pursuit for recognition of the 
anthrax germ, Koch sought the technical patronage 
of Cohn, a botanist. Cohn’s encouragement enabled 
publication of their joint drawings of the anthrax 
bacillus when Koch was only 32 years old.12 Koch 
however, built upon their achievements and stole 
a march on his mentors and collaborators by his 
elegant animal experiments and ingenious culture 
techniques that were verifiable and reproducible. 
They resulted in the eponymous Henle-Koch’s 
postulates that stipulated that an organism could 
be considered the cause of an infectious disease if: 
(1) it occurred in every case of the disease; (2) it 
did not occur in other diseases or non-pathogenic 
conditions, and (3) after isolation and growth in 
culture, it could produce the same disease when 
inoculated into a healthy animal.13
A Technologist Par 
Excellence
In vivo and in vitro innoculations in the cornea 
and aqueous humour; establishing superiority of 
solid- over liquid-based media for obtaining pure 
cultures; microscopy and illumination methods; 
the fixation of bacterial smears on slides, and a host 
of stains that made it easy to identify bacteria (the 
alkaline methylene blue solution stained tubercular 
bacteria that contrasted with the background tissue 
stained with the Vesuvin brown dye) are some of 
the significant ‘bench’ methods which Koch toiled 
to produce [Figure 1].7 These became the bedrock 
methods of modern bacteriological laboratories. 
It is noteworthy that his co-workers, Hesse and 
Petri, were responsible for the establishment of 
agar as a vital base for solid media and the shallow 
‘petri’ dish, respectively.5 Koch’s comprehensive 
approach to the scientific method is illustrated by 
his integration of these exacting techniques with 
animal innoculations and, in the case of cholera, 
with autopsies.14 Koch is also credited with 
replacing pencil drawings by microphotography as 
an established tool for scientific documentation and 
Figure 1: Original drawing by Koch of tubercle bacilli 
within infected tissue which accompanied his 
groundbreaking report on the aetiology of tuberculosis.7 
Figure reproduced with permission.
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Robert Koch Institute in his honour. The million 
marks provided by the banker Bleichroeder to 
transform the erstwhile government house into this 
institute is a telling comment on the relevance of 
financial patronage for science and research.4 The 
Nobel Prize for Medicine and Physiology, bestowed 
on him in 1905, recognised both his discovery of 
the tubercular bacillus and its monumental 
impact on public hygiene measures, as well as 
the pioneering impact of his postulates on the 
broader understanding of infectious diseases 
as a whole.2 At the same time, the Nobel Prize 
presentation speech, with equal clarity, offered 
a critique on the controversy surrounding his 
ongoing experimentation with tuberculin as a 
form of therapy. Since 1982, 24th February has been 
designated ‘World Tuberculosis Day’ by the World 
Health Organization (WHO) to honour the day 
Koch first presented his findings on the aetiology 
of TB.
Frustrations, Dissent and 
Disappointment
The history of discoveries is replete with human 
emotions of exultation and despair. Convinced 
of his proposed ‘germ theory’ Koch went to great 
lengths to see, and show his sceptical colleagues, the 
germs that circulated in the blood in septicaemia. 
This, as we can well imagine, was no easy task but 
he developed the simple potato medium that would 
make the organisms multiply. Complemented with 
staining techniques, the organisms were revealed 
in all their glory. The Koch-Pasteur squabbles 
based on the physician versus chemist approach to 
disease created political boundaries that prevented 
the use of Koch’s culture techniques and Pasteur’s 
immunisation schedules in France and Germany, 
respectively.16 Elated by his triumphal march on TB 
he attempted to prove that tuberculin (a glycerine 
extract of the tubercle bacilli) would provide a cure 
for the disease. While tuberculin proved useful in 
diagnosis, it met with disappointment and failure in 
therapy.7 After the revolutionary highpoints of his 
early career, this setback was particularly difficult 
to accept. At the Fourth World Congress on TB, 
he vehemently opposed the notion that bovine TB 
could spread to humans, declaring, “I therefore 
consider it unnecessary to take any measures against 
this form of TB. The fight against TB clearly has to 




A child prodigy, Koch had astonished his parents 
when, at the age of five, they learnt that he had 
taught himself to read through newspapers; it 
was no surprise that he went on to graduate 
maxima cum laude in his M.D. in 1866.15 The 
motto nunquam otiosus (Latin: never idle) was the 
driving force behind the prodigious contributions 
of this man who was passionate in equal measure 
about biological sciences, nature and travel. This 
drove him from the temples of learning in France, 
Berlin, London and Hannover to exotic locations 
like Alexandria and Calcutta. The hallmarks of 
his life’s mission were technological excellence 
and indisputable scientific logic. These stood 
him in good stead in convincing—where others 
had failed—his hard-nosed scientific peers of the 
veracity of the hotly-debated ‘germ theory’.
The economics of animal husbandry has often 
spearheaded ground-breaking research in human 
disease. Others before Koch had recognised the 
anthrax bacilli in the blood of infected animals, but 
failed to establish its transmissibility. Koch persisted 
and was able to establish growth of the bacilli in 
culture and observe the formation of spores: “After 
anthrax bacilli develop for a short time, shiny 
egg-shaped bodies form in the filaments. Shortly 
thereafter, the filaments decompose… If they are 
placed in a nourishing medium, they germinate 
and grow into rods and then into long filaments”.16 
This sound scientific observation succeeded in 
explaining the time-lag in the transmission of the 
disease between animals. It predated the deluge of 
attention showered on him after the identification 
of the tubercle bacillus.
Accolades and Patronage
Koch’s success earned him the Order of the 
Crown, 100,000 marks and appointments such as 
Privy Imperial Councillor by Emperor Wilhelm I, 
Professor of Hygiene at the University of Berlin and 
Director of the Hygiene Institute.4,15 He then went on 
to head the newly established Institute of Infectious 
Diseases which, after his death, was renamed the 
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concentrate on the human bacillus”.17 Fortunately, 
his opponents won the day and milk pasteurisation 
became the norm.18
And the Story Continued...
The indefatigable war against TB continued in 
the wake of Koch’s discoveries and extended to 
other medical domains. Roentgen’s discovery of 
X-rays in 1896 was a giant leap forward in medical 
diagnostic tools.19 In addition to public health 
measures, the French bacteriologists Calmette 
and Guérin’s bovine tubercular strain created the 
Bacillus Calmette–Guérin (BCG) vaccine that 
turned the tide from a therapy-only approach to 
TB to one of active prevention.20 In 1944, for the 
first time, streptomycin showed a light at the end 
of the tunnel—although monotherapy left many 
with hearing loss for the rest of their lives. Soon, 
other drugs (rifampicin, pyrazinamide, para-amino 
salicylic acid, ethambutol, etc.) joined the fray and 
the philosophy of treatment rested on combinations 
in adequate doses for long periods of time. Since 
1993, the adoption of the Directly Observed 
Treatment, Short-Course (DOTS) strategy by the 
WHO, as part of its Stop TB strategy, is credited 
with having made a significant impact on the global 
TB burden.21
Like many bacteria, the tubercular bacterium 
adopted wily ways of acquiring multi-drug 
resistance and the battle between it and newer 
drugs continues. Since the turn of the last century, 
the HIV-AIDS epidemic has rendered a mortal blow 
to attempts to control TB, especially in Sub-Saharan 
Africa. Industrialisation, urban slums and poverty 
are no longer the only determinants of disease 
prevalence. It is certain that as newer epidemics 
emerge, ‘old’ infections like the ‘white plague’ will 
seize the advantage and challenge generations of 
scientists to fight back through gruelling research 
efforts and newer weaponry. 
Lessons From Koch’s Life 
and Times
Henle’s influence and Cohn’s support in Koch’s 
early experiments show us that pupils often surpass 
their gurus and surprise their peers by trailblazing 
their way into eternity. In today’s world of sub-
specialisation, it is pertinent to recall that a well-
rounded knowledge of pathology and bacteriology 
integrated with a physician’s knowledge of human 
disease, combined with technology, microscopy, 
animal experiments and autopsies have been the 
mantra for the deluge of successful discoveries in the 
last two centuries. The discovery of the spore stage 
of bacterial dormancy in anthrax demonstrates that 
a hands-on approach to the laboratory bench can 
yield unexpected and astonishing results. Koch’s 
investigative forays as a district medical officer into 
anthrax were inspired by the affliction of country 
cattle in his rural backyard and his experiments 
were first performed in a makeshift laboratory in 
his own house on mice caught in his barn! His wife’s 
resilience and support needs no better endorsement. 
Research rests first and foremost on the ‘spirit’ of 
enquiry. Funding, state-of-art laboratories and fame 
are not necessary pre-requisites. 
Koch’s insistence on use of tuberculin for 
therapy, despite the incontrovertible evidence to 
the contrary, illustrates the fact that spectacular 
discoveries may be followed by offbeat theories that 
are anticlimactic. Fame and acclaim can impose an 
unreasonable burden of expectations for a single 
man’s lifetime.
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